ScholarLens Back to search
2014•International Journal of HematologyRequires access

Autologous stem cell transplantation for AL amyloidosis: adjustment of melphalan dose by factors including BNP

Toshiaki Hayashi, Hiroshi Ikeda, Tetsuyuki Igarashi, Yumiko Maruyama, Yuka Aoki, Masanori Nojima, Tadao Ishida, Yasuhisa Shinomura

Open publisher page 11 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 11 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Melphalan, AL amyloidosis, Medicine, Autologous stem-cell transplantation, Internal medicine, Creatinine, Transplantation, Amyloidosis

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Autologous stem cell transplantation for AL amyloidosis: adjustment of melphalan dose by factors including BNP — Research Paper | ScholarLens